uniQure (QURE) Shares Outstanding (Weighted Average) (2015 - 2026)

uniQure (QURE) recorded quarterly Shares Outstanding (Weighted Average) of $62.7 million in Q1 2026, up 9.11% quarter-over-quarter from $57.5 million in Q4 2025, and up 18.14% on a YoY basis from $53.1 million in Q1 2025.

uniQure (QURE) Shares Outstanding (Weighted Average) (2015 - 2026) Analysis & Trends

uniQure's Shares Outstanding (Weighted Average) history runs 12 years deep, the most recent figure standing at $62.7 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Weighted Average) rose 18.14% year-over-year to $62.7 million; the TTM figure through Mar 2026 stood at $62.7 million (up 18.14% YoY), while the FY2025 annual figure was $57.5 million, up 18.2% from the prior year.
  • Shares Outstanding (Weighted Average) was $62.7 million for Q1 2026 at uniQure, up from $57.5 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $62.7 million in Q1 2026 to a low of $46.6 million in Q1 2022.
  • Historically, Shares Outstanding (Weighted Average) has averaged $50.5 million across 5 years, with a median of $48.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) gained 1.29% in 2022, then increased 20.46% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $46.7 million in 2022, then advanced by 2.0% to $47.7 million in 2023, then climbed by 2.05% to $48.6 million in 2024, then grew by 18.2% to $57.5 million in 2025, then increased by 9.11% to $62.7 million in 2026.
  • The last three Shares Outstanding (Weighted Average) figures came in at $62.7 million (Q1 2026), $57.5 million (Q4 2025), and $58.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 185,491.37 Bn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 400.00 Bn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 100.00 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 417.01 Bn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 68.88 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 254.10 Mn
9 Abivax 91.96 Bn 91.96 Bn - 928.40 Mn
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 62.74 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 62.74 Mn
Dec 31, 2025 57.50 Mn
Sep 30, 2025 58.52 Mn
Jun 30, 2025 54.81 Mn
Mar 31, 2025 53.11 Mn
Dec 31, 2024 48.65 Mn
Sep 30, 2024 48.58 Mn
Jun 30, 2024 48.62 Mn
Mar 31, 2024 48.38 Mn
Dec 31, 2023 47.67 Mn
Sep 30, 2023 47.62 Mn
Jun 30, 2023 47.65 Mn
Mar 31, 2023 47.44 Mn
Dec 31, 2022 46.74 Mn
Sep 30, 2022 46.77 Mn
Jun 30, 2022 46.63 Mn
Mar 31, 2022 46.60 Mn
Dec 31, 2021 45.99 Mn
Sep 30, 2021 46.15 Mn
Jun 30, 2021 46.04 Mn